Human Gene Therapy

Titel Veröffentlichungsdatum Sprache Zitate
Development and Characterization of Recombinant Adenoviruses Encoding Human p53 for Gene Therapy of Cancer1994/09/01English150
Optimization of Fibronectin-Assisted Retroviral Gene Transfer into Human CD34+Hematopoietic Cells1997/12/10English150
Characterization of Genetically Altered, Interleukin 2-Independent Natural Killer Cell Lines Suitable for Adoptive Cellular Immunotherapy1999/05/20English149
Cancer Gene Therapy Using Plasmid DNA: Purification of DNA for Human Clinical Trials1995/05/01English149
Good Manufacturing Practices Production of Mesenchymal Stem/Stromal Cells2011/01/01English148
In VivoElectroporation for Gene Therapy2006/09/01English148
Experimental and Clinical Studies of Cytokine Gene-Modified Tumor Cells1994/02/01English147
Phase I Trial of Intranasal and Endobronchial Administration of a Recombinant Adeno-Associated Virus Serotype 2 (rAAV2)-CFTR Vector in Adult Cystic Fibrosis Patients: A Two-Part Clinical Study2003/07/20English147
Lymphoma Regression Induced by Ganciclovir in Mice Bearing a Herpes Thymidine Kinase Transgene1990/07/01English147
Dopaminergic Cell Loss Induced by Human A30P α-Synuclein Gene Transfer to the Rat Substantia Nigra2002/03/20English146
Systemic Antitumor Immunity in Experimental Brain Tumor Therapy Using a Multimutated, Replication-Competent Herpes Simplex Virus1999/11/20English146
Adenovirus-Mediated Gene Transfer to Lower Limb Artery of Patients with Chronic Critical Leg Ischemia1998/07/01English146
Impact of Preexisting and Induced Humoral and Cellular Immune Responses in an Adenovirus-Based Gene Therapy Phase I Clinical Trial for Localized Mesothelioma1998/09/20English146
Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models2017/04/01English145
In VivoTracking of Neural Progenitor Cell Migration to Glioblastomas2003/09/10English142
Effective Targeting of Multiple B-Cell Maturation Antigen–Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells2018/05/01English142
The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon2009/10/01English142
Transferrin-Liposome-Mediated Systemic p53 Gene Therapy in Combination with Radiation Results in Regression of Human Head and Neck Cancer Xenografts1999/12/10English142
Targeting Human Papillomavirus Type 16 E7 to the Endosomal/Lysosomal Compartment Enhances the Antitumor Immunity of DNA Vaccines against Murine Human Papillomavirus Type 16 E7-Expressing Tumors1999/11/20English140
In Vivo Trafficking and Targeted Delivery of Magnetically Labeled Stem Cells2004/04/01English140
β-Galactosidase Gene Transfer to Human Malignant Glioma In Vivo Using Replication-Deficient Retroviruses and Adenoviruses1998/08/10English140
Efficient Transduction of Mammalian Cells by a Recombinant Baculovirus Having the Vesicular Stomatitis Virus G Glycoprotein1997/11/20English140
Cancer Gene Therapy Using Plasmid DNA: Pharmacokinetic Study of DNA Following Injection in Mice1995/05/01English140
Polarity Influences the Efficiency of Recombinant Adenoassociated Virus Infection in Differentiated Airway Epithelia1998/12/10English140
A Phase 1-2 Clinical Trial of Gene Therapy for Recurrent Glioblastoma Multiforme by Tumor Transduction with the Herpes Simplex Thymidine Kinase Gene Followed by Ganciclovir1999/09/20English139
Prospects for the Use of Adeno-Associated Virus as a Vector for Human Gene Therapy1994/07/01English139
Herpes Simplex Virus Thymidine Kinase Gene Transfer for Controlled Graft-versus-Host Disease and Graft-versus-Leukemia: Clinical Follow-up and Improved New Vectors1998/10/10English138
Retroviral Vectors for High-Level Transgene Expression in T Lymphocytes2003/08/10English137
Biology of Adenovirus and Its Use as a Vector for Gene Therapy2004/11/01English137
Challenges in CRISPR/CAS9 Delivery: Potential Roles of Nonviral Vectors2015/07/01English136